A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India
Clinical trial NCT05659537 · COMPLETED
Trial details
- NCT number
- NCT05659537
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-29
- Primary completion
- 2024-01-16
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.